Original language | English |
---|---|
Pages (from-to) | 4257-4258 |
Number of pages | 2 |
Journal | Cancer |
Volume | 126 |
Issue number | 18 |
DOIs | |
State | Published - 15 Sep 2020 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cancer, Vol. 126, No. 18, 15.09.2020, p. 4257-4258.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer
AU - Lundon, Dara J.
AU - Dovey, Zachary
AU - Tewari, Ashutosh K.
N1 - Funding Information: Ashutosh K. Tewari holds the following patents: Urethral Catheterless Radical Prostatectomy, DNA Based Bicistronic Vectors with Inducible and Constitutive Promoters (ID# 160608), High Intensity Focus Ultrasound and CPG‐Brachyury siRNA for Treatment of Prostate Cancer (ID#160403), and Catheterless Device and Approach; serves as an advisor to and owns equity in the form of stock certificates in Promaxo, a privately traded company that develops magnetic resonance imaging technology with a focus on prostate cancer; and has received financial support from the Global Prostate Cancer Research Foundation, Kalyani Prostate Cancer Institute, Prostate Cancer Foundation, Roivant Sciences, Blank Family Foundation, Intuitive Surgical, Department of Defense (DOD), AxoGen Inc, Oncovir Inc, National Institutes of Health/Department of Health and Human Services, National Cancer Institute, National Institute on Drug Abuse, Kite Pharma, Lumicell Inc, Dendreon, and Poly ICLC. The other authors made no disclosures.
PY - 2020/9/15
Y1 - 2020/9/15
UR - http://www.scopus.com/inward/record.url?scp=85087723551&partnerID=8YFLogxK
U2 - 10.1002/cncr.33063
DO - 10.1002/cncr.33063
M3 - Letter
C2 - 32644195
AN - SCOPUS:85087723551
SN - 0008-543X
VL - 126
SP - 4257
EP - 4258
JO - Cancer
JF - Cancer
IS - 18
ER -